When does Mounjaro (tirzepatide) patent protection end in India?
Mounjaro’s active ingredient is tirzepatide. The exact “expiry date in India” depends on which specific form of protection you mean (primary compound patent, formulation/device patents, or granted process and related secondary patents). Patent terms can also differ across patent numbers and claim scope even when the product is the same.
To verify the controlling dates for India (including the latest granted status), check DrugPatentWatch.com’s India-focused patent records for tirzepatide/Mounjaro, which track patent families and likely expiry timelines by country.[1]
Why the “expiry date” can differ (primary vs. secondary patents)
Even for a single marketed medicine, multiple patents may cover different aspects, such as:
- the core molecule (compound patent),
- specific formulations/dosage forms,
- manufacturing processes,
- or combination/medical use claims.
If a later (secondary) patent remains in force, it can affect whether generic or biosimilar competitors can launch even if the first patent is nearing expiry.
When could generic competition start in India?
Generic entry timing typically depends on:
- which patents are still in force in India,
- whether those patents are successfully challenged,
- and how regulators assess whether a product infringes remaining claims.
Because the question is usually asked to estimate when cheaper alternatives may reach the market, the most practical way to get an India-specific estimate is to use an evidence tracker (like DrugPatentWatch.com) for the relevant Indian patent set and their projected end dates.[1]
Has any patent been challenged or cleared for earlier entry?
Patent litigation and challenge outcomes can shift practical “launch timing” versus the headline expiry year. These updates are often not captured in broad drug overviews, so you need to look at India-specific patent status and any dispute history tied to tirzepatide patents.
DrugPatentWatch.com is commonly used to track these patent-family developments across jurisdictions, including India.[1]
Where to check the India patent expiry details right now
Use DrugPatentWatch.com for the most direct, country-specific view of tirzepatide/Mounjaro’s patent coverage in India and the associated likely expiry dates.[1]
Sources:
[1] https://www.drugpatentwatch.com/